Defibrillator News

Zenerx review

2007-04-11T09:42:00.000-07:00

The allopathic treatment is also available for ED. There are large numbers of ED drugs available in the market that promises the patient a relief from those embarrassing sexual moments. The choice of these drugs is really critical as they can over react sometimes if taken in excess. You must therefore, consult your doctor before commencing the course of ED drugs. Here are some of the most common and trusted ED drugs available in the market:

Viagra
Levitra
Cialis
Zenerx

hemroids heal more quickly

2006-09-10T09:47:00.000-07:00

Drinking plenty of liquids that are non-caffeinated will also help constipation fade quickly if hemroids do appear, keeping the inflammation to a minimum. Simple things like keeping the area clean and wiping gently with non-perfumed, non-colored toilet paper will help the hemroids heal more quickly.

Factoring

2006-06-30T00:33:00.000-07:00

Biphasic Defibrillation

Until recently, external defibrillators relied on monophasic shock waves. Electrical pulses are sent rapidly from one electrode to the other, only in one direction. Biphasic defibrillation, however, alternates the direction of the pulses, completing one cycle in approximately 10 milliseconds. Biphasic defibrillation was originally developed and used for implantable cardioverter-defibrillators. When applied to external defibrillators, biphasic defibrillation significantly decreases the energy level necessary for successful defibrillation. This, in turn, decreases risk of burns and myocardial damage. However, there is limited evidence to suggest that biphasic defibrillation is superior to monophasic defibrillators, although the small capacitor size required for the defibrillator can result in significant cost and size savings-- essential for the proliferation of Automated External Defibrillators.

Guidant Recall - Guidant Pacemaker Defibrillator Recall

2006-04-07T23:12:00.000-07:00

Guidant Recall - Guidant Pacemaker Defibrillator Recall: "Guidant Related Deaths
Heart disease continues as one of the biggest killers in the United States. Heart failure, also known as cardiac arrest, occurs when the heart stops pumping blood properly. This illness leads to 200,000 to 400,000 deaths per year.

The Guidant devices are designed to extend the lives of heart disease patients, but if a defibrillator is defective, it could have devastating effects, including patient death. When the Guidant devices are defective, either the irregularity of the heart rate is not detected or the proper electrical impulses for treatment are not delivered to the heart. If the proper therapy is not provided, the heart can cease proper functioning and the patient could perish or suffer serious injuries due to lack of proper blood flow.

It is Guidant's responsibility to maintain the highest quality standards for their pacemaker and defibrillator products and insure that if any quality issue arises, immediate steps are taken to protect the patients. Two deaths have been reported to date related to the Guidant defibrillator recall defect."

Defibrillator - Wikipedia, the free encyclopedia

2006-04-06T03:43:00.000-07:00

Defibrillator - Wikipedia, the free encyclopedia: "Biphasic Defibrillation

Until recently, external defibrillators relied on monophasic shock waves. Electrical pulses are sent rapidly from one electrode to the other, only in one direction. Biphasic defibrillation, however, alternates the direction of the pulses, completing one cycle in approximately 10 milliseconds. Biphasic defibrillation was originally developed and used for implantable cardioverter-defibrillators. When applied to external defibrillators, biphasic defibrillation significantly decreases the energy level necessary for successful defibrillation. This, in turn, decreases risk of burns and myocardial damage. However, there is limited evidence to suggest that biphasic defibrillation is superior to monophasic defibrillators, although the small capacitor size required for the defibrillator can result in significant cost and size savings-- essential for the proliferation of Automated External Defibrillators."

LIFECOR - LifeVest

2006-04-02T22:47:00.000-07:00

LIFECOR - LifeVest: "

When to Use the LifeVest™ System

The LifeVest was designed as an intermediate-term treatment option for people at high risk for sudden cardiac arrest (SCA). Right now, people at a high, short-term risk of SCA are typically monitored in a hospital intensive care (ICU) or coronary care unit (CCU). With monitored beds costing up to $2,000 a day, this option quickly becomes very expensive and is primarily reserved for critical care patients.

Patients with a high, long-term risk of SCA are often candidates for an implantable cardioverter defibrillator (ICD), but this option is also expensive (up to $65,000) and requires surgery. According to Morgan Stanley, only one out of six US patients who need an ICD actually get one.*

The LifeVest fills the therapeutic gap between hospitalization and an ICD. The LifeVest has the same important characteristics of both an ICU/CCU and the ICD; it continuously monitors the heart and is designed to provide prompt defibrillation when needed. LIFECOR®, Inc. believes that the LifeVest has the potential to become the standard of care for intermediate-term patients. And, in cases when an ICD is not feasible, it also can serve as a longer-term alternative."

American Heart Association Praises Senate Passage of Defibrillator Legislation

2006-03-14T23:54:00.000-08:00

American Heart Association Praises Senate Passage of Defibrillator Legislation: "ALBANY - The American Heart Association today commends the New York State Senate for passing legislation that will expand New York State's Public Access to Defibrillation program by requiring all high occupany facilities to be equipped with an automated external defibrillator (AED). All publicly- and privately-operated facilities having a capacity for occupancy by 1,000 or more persons will be required to be equipped with a minimum of one AED and have at least one employee trained in CPR and the use of an AED to be present when the facility is in use.

This legislation, which was passed by the New York State Assembly on May 26th, empowers New York State residents to respond to a cardiac emergency.

Now, it awaits the signature of New York State Governor George Pataki.

'The Senate has shown it understands how critical improving the chain of survival for cardiac arrest victims is,' said Paul Hartman, Director of Advocacy for the American Heart Association. 'If signed by Governor Pataki, this legislation will grow New York's current public access defibrillation program by bringing lifesaving defibrillators into our state's largest public and private venues.'

This legislation, which was passed by the New York State Assembly on May 26th, empowers New York State residents to respond to a cardiac emergency.

Now, it awaits the signature of New York State Governor George Pataki.

"The Senate has shown it understands how critical improving the chain of survival for cardiac arrest victims is," said Paul Hartman, Director of Advocacy for the American Heart Association. "If signed by Governor Pataki, this legislation will grow New York's current public access defibrillation program by bringing lifesaving defibrillators into our state's largest public and private venues."

The legislation (S.1074), sponsored by Senator James Alesi (R - East Rochester), extends "Good Samaritan" protections to trained employees and volunteers who use the AED in an emergency situation at such facilities. Identical legislation (A.112) was sponsored by Assemblyman Harvey Weisenberg (D - Long Beach).

About 250,000 people die each year from sudden cardiac arrest. Defibrillation is the only known therapy to treat an individual in cardiac arrest. The delivering of an electrical shock to the heart can restore the heart's normal rhythm. However, it must be done within minutes of the arrest. For every minute that passes without defibrillation, a victim's chance of survival decreases by seven to 10 percent. After as few as 10 minutes, very few resuscitation attempts are successful.

In the past, the ability to defibrillate rested solely in the hands of emergency medical personnel. Unfortunately, quick emergency medical response isn't always possible.

"The best way to give New Yorkers who suffer sudden cardiac arrest a chance for survival is to ensure the high-capacity facilities are equipped with lifesaving equipment, and that appropriate personnel are trained in CPR and in the use of an AED," Hartman said. "We know that this legislation will save lives, and we can't stress that fact enough."

In December 2002, New York State became the first state in the nation to require AEDs in schools and at all school sporting and extracurricular events. In February, the New York City Council unanimously passed legislation, and Mayor Bloomberg signed into law legislation that requires AEDs to be available in many public places, including city-owned buildings, parks, stadiums, senior centers, nursing homes, and golf courses. New York State has served as the national leader in enacting public policy to expand public access defibrillation -- requiring AEDs in schools, health clubs, and all state buildings and institutions. Most importantly, the AEDs-in-schools law alone has resulted in 18 saved lives since December 2002.

Defective Heart Defibrillators Recalled by Guidant Corporation
Defective Heart Defibrillators Recalled by Guidant Corporation 2
• E Defibrillator com Explains the Benefits of Portable Defibrillators
• E Defibrillator com Explains the Function of Defibrillators
• Frequently Asked Questions about the Guidant Recall
• Guidant Defibrillator Patients Urged to Register For Information Updates
• Plano Man Sues Over Flawed Heart Defibrillator
Sitemap

Implantable Cardioverter Defibrillator

2006-03-12T09:03:00.000-08:00

Implantable Cardioverter Defibrillator: "
Implantable Cardioverter Defibrillator

An implantable cardioverter defibrillator is used in patients at risk for recurrent, sustained ventricular tachycardia or fibrillation.

The device is connected to leads positioned inside the heart or on its surface. These leads are used to deliver electrical shocks, sense the cardiac rhythm and sometimes pace the heart, as needed. The various leads are tunnelled to a pulse generator, which is implanted in a pouch beneath the skin of the chest or abdomen. These generators are typically a little larger than a wallet and have electronics that automatically monitor and treat heart rhythms recognized as abnormal. Newer devices are smaller and have simpler lead systems. They can be installed through blood vessels, eliminating the need for open chest surgery.

When an implantable cardioverter defibrillator detects ventricular tachycardia or fibrillation, it shocks the heart to restore the normal rhythm. New devices also provide overdrive pacing to electrically convert a sustained ventricular tachycardia, and 'backup' pacing if bradycardia occurs. They also offer a host of other sophisticated functions (such as storage of detected arrhythmic events and the ability to do 'noninvasive' electrophysiologic testing).

Implantable cardioverter defibrillators have been very useful in preventing sudden death in patients with known, sustained ventricular tachycardia or fibrillation. Studies are now being done to find out how best to use them and whether they may have a role in preventing cardiac arrest in high-risk patients who haven't had, but are at risk for, life-threatening ventricular arrhythmias.

According to the American Heart Association Heart and Stroke Statistical Update, in 1998 (the most recent statistics available) there were 26,000 ICD procedures.

ARTICLES IN FILE
1	Plano-Man-Sues-Over-Flawed-Heart-Defibrillator
2	Guidant Defibrillator Patients Urged to Register For Information Updates
3	Frequently Asked Questions about the Guidant Recall
4	E Defibrillator com Explains the Function of Defibrillators
5	E Defibrillator com Explains the Benefits of Portable Defibrillators
6	Defective Heart Defibrillators Recalled by Guidant Corporation 2
7	Defective Heart Defibrillators Recalled by Guidant Corporation

Defibrillator News

Zenerx review

hemroids heal more quickly

Factoring

Guidant Recall - Guidant Pacemaker Defibrillator Recall

Defibrillator - Wikipedia, the free encyclopedia

LIFECOR - LifeVest

American Heart Association Praises Senate Passage of Defibrillator Legislation

Implantable Cardioverter Defibrillator

Great Defibrillators win "The Ridge Goes Red 2005"

American Heart Association Provides Area Police with Lifesaving Defibrillators

Ventricular Fibrillation

Public Use of Automated External Defibrillators

Automated External Defibrillators (AEDs)

Implantable Cardioverter Defibrillator

American Heart Association Praises Senate Passage of Defibrillator Legislation

Terrorist attacks increased dangerous irregular heartbeats

Public access defibrillator use increasing

Anger, exertion can spark irregular beat in patients with implantable defibrillators

MADIT II Trial -- Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction

Internal Cardioverter Defibrillator (ICD) and Antiarrhythmic Drug Interaction

Defibrillation

Response to Food and Drug Administration clearance of automated external defibrillator for home use

New drug reduces abnormal heart rhythms in patients with implanted cardioverter defibrillators

Implantable defibrillators cost-effective for preventing sudden death

Arrhythmia

Preventing sudden death with implantable defibrillators

Implantable Cardioverter Defibrillator